Publikationen, an denen er mitarbeitet Miguel Torralba González de Suso (10)

2021

  1. Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study

    BMC Infectious Diseases, Vol. 21, Núm. 1

2020

  1. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2016

  1. Executive summary: Prevención y tratamiento de infecciones oportunistas y otras coinfecciones en pacientes infectados por el VIH: mayo de 2015

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 8, pp. 517-523

  2. Prevention and treatment of opportunistic infections and other coinfections in HIV-infected patients: May 2015

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 8, pp. 516.e1-516.e18

2004

  1. Clinical, Virologic, and Immunologic Response to Efavirenz- or Protease Inhibitor-Based Highly Active Antiretroviral Therapy in a Cohort of Antiretroviral-Naive Patients with Advanced HIV Infection (EfaVIP 2 Study)

    Journal of Acquired Immune Deficiency Syndromes, Vol. 35, Núm. 4, pp. 343-350

2002

  1. Estudio epidemiológico retrospectivo sobre la duración del tratamiento de la infección por el virus de la inmunodeficiencia humana en España

    Medicina Clinica, Vol. 119, Núm. 19, pp. 721-724

  2. High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/μl and opportunistic diseases: The Efa VIP study (Efavirenz in very immunosuppressed patients)

    AIDS, Vol. 16, Núm. 11, pp. 1554-1556

  3. Lipid changes in HIV-infected patients who started rescue therapy with an amprenavir/ritonavir-based highly active antiretroviral therapy [3]

    AIDS

  4. NNRTI hepatotoxicity: efavirenz versus nevirapine.

    Journal of HIV therapy, Vol. 7 Suppl 2

2001

  1. Efficacy and toxicity of treatment with efavirenz or indinavir plus zidovudine and lamivudine: An approach according to evidence-based medicine

    Enfermedades Emergentes, Vol. 3, Núm. 1, pp. 28-32